Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Patent
1995-05-04
1996-12-24
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
A61K 31045
Patent
active
055874029
ABSTRACT:
A method for causing regression of a leukemia cell tumor is disclosed. This method comprises the step of administering perillyl alcohol to a tumor-containing mammal.
REFERENCES:
patent: 5110832 (1992-05-01), Chastain
patent: 5244916 (1993-09-01), Bokoch
Elegbede, et al., "Inhibition of DMBA-induced Mammary Cancer By the Monoterpene D-Limonene,"Carcinogenesis, 5[5]:661-664, (1984).
Elegbede, et al., "Regression of Rat Primary Mammary Tumors Following Dietary d-Limonene," JNCI, 76[2]:323-325 (1986).
Haag, et al., "Limonene-induced Complete Regression of Rat Mammary Carcinomas," Proc. Of The Amer. Assoc. For Cancer Research, 32:402 Abs #2391 (1991).
Elson, et al., "Anti-carcinogenic Activity of d-limonene During the Initiation And Promotion/Progression Stages of DMBA-induced Rat Mammary Carcinogenesis," Carcinogenesis, 9[2]331:332 (1988).
Maltzman, et al., "The Prevention of Nitrosomethylurea-induced Mammary Tumors by d-Limonene and Orange Oil,", Carcinogenesis, 10[4]:781-783 (1989).
Wattenberg, et al., "Inhibition Of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-Butanone Carcinogenesis In Mice By D-limonene And Citrus Fruit Oils," Carcinogenesis, 12[1]:115-117 (1991).
Van Duuren, et al., "Cocarcinogenic And Tumor-Promoting Agents In Tabacco Carcinogenesis," Journ. of the Natl. Cancer Institute, 56[6]:1237-1242 (1976).
Homburger, et al., "Inhibition of Murine Subcutaneous And Intraveneous Benzo(rst)pentaphene Carcinogensis By Sweet Orange Oils and D-Limonene," Oncology, 25:1-10 (1971).
Crowell, et al., "Selective Inhibition Of Isoprenylation Of 21-26kDa Proteins By The Anticarcinogen d-Limonene And Its Metabolites," The Journ. of Biol. Chem., 266[26]:17679-17685 (Sep. 1991).
Gould, "Chemoprevention And Treatment Of Experimental Mammary Cancers By Limonene," Proc. of the Amer. Assoc. For Cancer Res., 32:474-475 (1991).
Abtract 3134, Crowell, et al., "Human Metabolism of Orally Adminstered D-Limonene," Proc. Of the Amer. Assoc. For Cancer Research, 33:524 (1992) (see also 3135).
Crowell, et al., "Identification of Metabolites of the Antitumor Agent d-limonen Capable of Inhibiting Protein Isoprenylation and Cell Growth," Cancer Chemotherapy and Pharmacology, 31:205-212, 1992.
Crowell, et al., "Chemoprevention of Mammary Carcinogenesis By Hydroxylated Derivative of d-limonene," Carcinogenesis, 13(7):1261-1264 (1992).
Haag, et al., "Limonene-induced Regression of Mammary Carcinomas," Cancer Research, 52:4021-4026 (1992).
Ren, et al., "Inihibition of Ubiquinone and Cholesterol Synthesis by the Monoterpene Perillyl Alcohol," Cancer Letters, 76:185-190 (1994).
W. Shi, et al., "Differentiation of Neuro-2a Cells Induced by the Monoterpene, Perillyl Alcohol (POH)," Proc. Of The Amer. Assoc. For Cancer Research, 34:548 (1993).
Ren, et al., "Inhibition of Ubiquinone Biosynthesis by the Monoterpene Perillyl Alcohol (POH)," Proc. Of The Amer. Assoc. For Cancer Research, 34:548 (1993).
Plenary Session 4: Mechanisms of action of chemopreventive agents: Basic science and clinical applications, Gould, et al., "Chemoprevention of mammary cancer by monoterpenes," Proceedings, Eighty-Fourth annual Meeting, American Association for Cancer Research p. 572-73, vol. 34 (1993).
Gould, et al., Proposal, "Phase I Evaluation of Perillyl Alcohol (NSC 641066) in Patients With Cancer," distributed in Aug., 1993.
Gould, et al., "Perillyl Alcohol (NSC 641066) Summary of Activities in the Development Therapeutics Program, DCT, NCI," distributed in Feb., 1994.
Gould, et al., "Perillyl Alcohol (NSC 641066) and Limonene (NSC 844) Summary for the Decision Network," distributed in Feb., 1994.
Crowell, et al., "Structure-Activity Relationships Among Monoterpene Inhibitors of Protein Isoprenylation and Cell Proliferation," Biochemical Pharmacology, 47:14-15, 1994.
Gould, et al., "Cellular and Molecular Aspects of the Multistage Progression of Mammary Carcinogenesis in Humans and Rats," Cancer Biology, 4;161-169 (1993).
Clark, et al., "Molecular Pathogenesis of Ph-Positive Leukemias," Ann. Rev. Med., 40:113-22 (1989).
Abstract 3135, Haag, et al., Proceedings of the Eighty-Third Annual Meeting of the American Association for Cancer Research, vol. 33, p. 524, Mar. 1992.
Ren, et al., "Inhibition of ubiquinone and cholesterol synthesis by the monoterpene perillyl alcohol," Cancer Letters 2[3]:185-190, 1994.
Bronfen, et al., "Inhibition of human pancreatic carcinoma cell proliferation by perillyl alcohol," Proc. Annu. Meet. Am. Assoc. Cancer Research 35:431, 1994.
Crowell, et al., "Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation," Biochem. Pharmacol. 47 [8]:1405-1415, 1994.
Clark Steven S.
Crowell Pamela L.
Elson Charles E.
Gould Michael N.
Goldberg Jerome D.
Wisconsin Alumni Research Foundation
LandOfFree
Regression of mammalian leukemia cell tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regression of mammalian leukemia cell tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regression of mammalian leukemia cell tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1178884